ADALIMUMAB
adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes
ADALIMUMAB (13292N)
13292N
Manner of administration:Injection
Restriction (Streamlined authority code: 17713)
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment
